HHMI
RVTY icon

Howard Hughes Medical Institute’s Revvity RVTY Stock Holding History

Howard Hughes Medical Institute’s Portfolio RVTY Stock Details RVTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$2.42K – 399
2025
Q4 		$2.42K Hold
25
– – ﹤0.01% 457
2025
Q3 		$2.19K Sell
25
-1
-4% -$91 ﹤0.01% 467
2025
Q2 		$2.52K Buy
+26
New +$2.45K ﹤0.01% 440

Other funds holding RVTY

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howard Hughes Medical Institute's RVTY Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Revvity (RVTY) in Q1 2026, closing a stake of 25 shares — an estimated $2.42K sold.

Howard Hughes Medical Institute first reported a position in RVTY in Q2 2025 and held it in 3 quarters. The position peaked at $2.52K in Q2 2025. 501 funds tracked by Wall St. Rank hold RVTY as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Revvity position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 25 Revvity shares in Q1 2026, an estimated $2.42K.
  • Howard Hughes Medical Institute first reported a position in Revvity in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Revvity position peaked at $2.52K in Q2 2025.
  • 501 funds tracked by Wall St. Rank held Revvity as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.